These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 5888288)

  • 21. Physiochemical stability of pharmaceutical phosphate buffer solutions. IV. Prevention of precipitation in parenteral phosphate solutions.
    Hasegawa K; Hashi K; Okada R
    J Parenter Sci Technol; 1982; 36(5):210-5. PubMed ID: 6927750
    [No Abstract]   [Full Text] [Related]  

  • 22. [Requisites and biological control of injectable aqueous solutions].
    SETNIKAR I
    Boll Chim Farm; 1959 Jul; 98():386-438. PubMed ID: 14445198
    [No Abstract]   [Full Text] [Related]  

  • 23. ["Intravascular volume effects of intravenous administration of 40% sorbitol solution"].
    Finsterer U
    Anaesthesist; 1981 Nov; 30(11):582-5. PubMed ID: 7316134
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of xylitol on the stability and morphological parameters of tablets with sorbitol made by direct tabletting of formulation components.
    Zgoda MM; Woskowicz M; Nachajski M; Haeusler O; Iwanczyk M
    Pharmazie; 2004 Aug; 59(8):651-3. PubMed ID: 15378860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Carbohydrate infusions in internal diseases. A comparative study on metabolically normal patients, patients with liver diseases and diabetics. Aims, execution and statistics of the studies in long-term infusion of carbohydrates].
    Malchow H; Horbach L
    Infusionsther Klin Ernahr; 1981 Oct; 8(5):218-23. PubMed ID: 7309223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [ON PREPARATION OF INFUSION FLUIDS].
    LEHMANN H
    Vierteljahrsschr Schweiz Sanitatsoff; 1964 Jul; 41():109-16. PubMed ID: 14249676
    [No Abstract]   [Full Text] [Related]  

  • 27. [Sorbitol].
    Storti F
    Ann Med Nav (Roma); 1968; 73(2):133-7. PubMed ID: 5736180
    [No Abstract]   [Full Text] [Related]  

  • 28. Study of local anaesthetics. Part 139. Preformulation study of N-[2-(2-heptyloxyphenylcarbamoyloxy)-ethyl] dimethylammonium chloride.
    Vitková Z; Gardavská K; Cizmárik J
    Acta Pharm Hung; 1996 Nov; 66(6):253-7. PubMed ID: 9604491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Compatibility and stability of dobutamine hydrochloride with large-volume parenterals and selected additives.
    Kirschenbaum HL; Aronoff W; Piltz GW; Perentesis GP; Cutie AJ
    Am J Hosp Pharm; 1983 Oct; 40(10):1690-1. PubMed ID: 6638033
    [No Abstract]   [Full Text] [Related]  

  • 30. [PRODUCTION OF CRYSTALLINE SORBITOL].
    POSPEEV AD
    Med Prom SSSR; 1964 Jul; 18():39-41. PubMed ID: 14232481
    [No Abstract]   [Full Text] [Related]  

  • 31. [Preparation of infusion solutions. II. Infusion solutions].
    MAIER JF
    Cesk Farm; 1953 Sep; 2(9):309-18. PubMed ID: 13116250
    [No Abstract]   [Full Text] [Related]  

  • 32. Continuous intravenous administration of drugs.
    Paris P; Hans P; Lamy M
    Acta Anaesthesiol Belg; 1983 Jun; 34(2):109-15. PubMed ID: 6613510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stabilizers for parenteral drugs.
    Scheindlin S
    Bull Parenter Drug Assoc; 1966; 20(2):61-4. PubMed ID: 5905230
    [No Abstract]   [Full Text] [Related]  

  • 34. [The effect of glycerin-sorbitol solution on intraocular pressure].
    Shen ZM
    Zhonghua Yan Ke Za Zhi; 1983 Jan; 19(1):21-2. PubMed ID: 6406186
    [No Abstract]   [Full Text] [Related]  

  • 35. [Correction of the ionic composition of isotonic saline solution].
    Barteczko I; Stechnij I; Halkiewicz A
    Pol Tyg Lek; 1982 Aug; 37(29-30):355-7. PubMed ID: 7155970
    [No Abstract]   [Full Text] [Related]  

  • 36. [Biopharmaceutical evaluation of preparations intended for the parenteral route].
    Aiache JM; Aiache S
    Boll Chim Farm; 1983 May; 122(5):213-28. PubMed ID: 6357232
    [No Abstract]   [Full Text] [Related]  

  • 37. A study of local anaesthetics. Part 148. Influence of auxiliary substances on the surface tension, distribution coefficient and pharmaceutical availability from solutions of the potential drug VII.
    Vitková Z; Gardavská K; Cizmárik J; Rak J
    Acta Pol Pharm; 1998; 55(6):453-6. PubMed ID: 10073132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The history of dosage form from the German Pharmacopoeia I to II of East Germany].
    Heise HG; Heise J
    Pharmazie; 1984 Jul; 39(7):445-61. PubMed ID: 6494224
    [No Abstract]   [Full Text] [Related]  

  • 39. [Study of insoluble contaminants in large-volume parental infusion fluids, II. Evaluation of the degree of contamination with insoluble particles of parenteral infusion fluids produced by the pharmaceutical industry and hospital pharmacies].
    Pawlaczyk J; Nowacka D; Wawrzyńczak D
    Acta Pol Pharm; 1982; 39(1-3):151-7. PubMed ID: 7180545
    [No Abstract]   [Full Text] [Related]  

  • 40. [Basis of infusion solutions. III. Systematization and directions for the use of infusion solutions].
    Schmitz JE; Ahnefeld FW
    Beitr Infusionther Klin Ernahr; 1980; 5():29-47. PubMed ID: 7192092
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.